Clean Science and
Information Technology · 2 quarters tracked · source-linked performance and management context.
Latest revenue
₹249 Cr
verified financial record
Quarters tracked
2
source records in the directory
Delivery assessment
Unscored
No scored management commitments are present yet.
Call date
2026-05-15
latest available source date
Signal trajectory
1 actual quarterCurrent read
Unscored
No scored management commitments are present yet.
Latest source read
What changed this quarter?
Clean Science reported a resilient Q4 FY26 with consolidated revenue of ₹246 crore (+14% QoQ) and EBITDA margin of 33%. Standalone revenue grew 8% QoQ to ₹193 crore, driven by volume recovery in flagship products. The health subsidiary achieved its first positive EBITDA of ₹7 crore, with volumes exceeding 1,000 tons and blended realizations improving to ₹460/kg. Management highlighted persistent pricing pressure from Chinese competition in MEHQ and anisol, but noted improved gross margins due to product mix. FY27 guidance remains cautious due to geopolitical uncertainty and crude price volatility. Key risks include inability to fully pass on raw material cost increases and potential oversupply from new domestic entrants.
Colored figures compare against the previous available record. Hover or focus one for the comparison.
Signal
Watch
Revenue
₹249 Cr
Source date
2026-05-15
Across the record
Quarter history.
History modules